Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead produ...
Psyence Biomedical FY26 net loss widens to about USD 6.89 million
Psyence Labs Discloses Investment in PSYENCE BIOMEDICAL LTD. with 30.05% Stake
Pacific Bay Corporate Update | PBMFF Stock News
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing | PBM Stock News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Why Is Psyence Biomedical Stock Falling Wednesday?